News
on
|
News Release
The National Institutes of Health has launched two of three adaptive Phase 3 clinical trials evaluating the safety and effectiveness of varying types of blood thinners to treat adults diagnosed with COVID-19. Part of the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) initiative, these trials will be conducted at more than 100...
|
Research Feature
NHLBI-funded researchers tackle big questions with large study of patients hospitalized with COVID-19 The doctors on the front lines of the coronavirus pandemic may be aware of the health impacts that face survivors of mass shootings or natural disasters, but the highly contagious virus—one of the deadliest in history—is forcing them to grapple...
|
Research Feature
In 2014 when the deadly Ebola virus was spreading like wildfire through parts of West Africa, Rear Admiral Richard Childs, M.D., led a team of physicians, nurses, engineers, and safety inspectors to Monrovia, Liberia to help treat the thousands of patients who had been infected. As the chief medical officer for the U.S. Public Health Service (USHPS...
|
News Release
Study is enrolling hospitalized adults with COVID-19 A clinical trial to evaluate the safety and effectiveness of hydroxychloroquine for the treatment of adults hospitalized with coronavirus disease 2019 (COVID-19) has begun, with the first participants now enrolled in Tennessee. The Outcomes Related to COVID-19 treated with hydroxychloroquine...